Clinical trial
SAFEstart Feeding Intolerance Study Phase II
NCT00331201 · Intermountain Health Care, Inc., Other · Completed
Key facts
| NCT number | NCT00331201 |
|---|---|
| Title | SAFEstart Feeding Intolerance Study Phase II |
| Official title | SAFEstart Treatment for NICU Patients With Feeding Intolerance; a Phase II Randomized, Controlled Trial |
| Lead sponsor | Intermountain Health Care, Inc., Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Feeding Intolerance, Abdominal Distention, Gastric Residual, Emesis and Diarrhea, Blood in Stool |
| Intervention type | Drug |
| Interventions | SAFEstart |
| Enrollment | 20 |
| Start date | Jul 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | May 29, 2006 |
| Last update posted | Nov 28, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: